Geneva: Unitaid, a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low- and middle-income...
Aurinia has nabbed its first FDA approval with an OK for Lupkynis (voclosporin) to treat lupus nephritis, or kidney inflammation caused by systemic lupus erythematosus. And now...
New Delhi: Though Delhi government runs 38 hospitals, over 200 dispensaries and polyclinics and 500 mohalla clinics, the Covid-19 outbreak demonstrated that the best of...
Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, Eli Lilly and Company (NYSE: LLY) announced....
New Delhi: Drug firm Alembic Pharmaceuticals today said the US health regulator has granted orphan drug designation to its associate company Rhizen Pharmaceuticals SA’s RP6530...
The slow pace of vaccination in many states and non-show by scheduled recipients reveal much scope for improvement. At current speed, it may be several...
New Delhi: Vaccine recipients in the second round of the anti-Covid immunisation — people above 50 and those who are younger but with co-morbidities —...
Thanks to dosing logistics, COVID-19 antibodies from Eli Lilly and Regeneron have gotten off to a slow start in the U.S., and now they’re facing a new stumbling block...
LONDON: Researchers have developed a new online tool that can calculate the risk of Covid-19 transmission in poorly-ventilated places, showing that when two people are...